Back to top
more

Select Medical (SEM)

(Real Time Quote from BATS)

$27.34 USD

27.34
102,936

-0.25 (-0.91%)

Updated Apr 16, 2024 12:44 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy18.00%
3Hold9.44%
4Sell5.10%
5Strong Sell2.53%
S&P50011.08%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 30% (175 out of 251)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Select Medical (SEM) Expands in Florida With UF Health JV

by Zacks Equity Research

Select Medical (SEM) inks a joint venture agreement with UF Health Jacksonville to open a 48-bed inpatient rehabilitation hospital in Florida.

Select Medical's (SEM) Concentra Submits Confidential IPO Filing

by Zacks Equity Research

The move from Select Medical's (SEM) Concentra highlights the recovery in the U.S. IPO market, especially for healthcare companies.

The Joint Corp. (JYNT) Moves 10.1% Higher: Will This Strength Last?

by Zacks Equity Research

The Joint Corp. (JYNT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Acadia Healthcare (ACHC) Q4 Earnings Beat on Strong Admissions

by Zacks Equity Research

Acadia Healthcare's (ACHC) Q4 results gain on strong growth in revenue per patient day. It expects adjusted EPS of $3.40-$3.70 for 2024, the mid-point of which implies a 3.2% rise from the 2023 reported figure.

Select Medical (SEM) Q4 Earnings Beat on Patient Admissions

by Zacks Equity Research

Select Medical's (SEM) Q4 results reflect strong segmental contribution, aided by higher patient days and visits. Management expects 2024 adjusted EBITDA to be $830-$880 million, up from the 2023 reported figure of $807.4 million.

Select Medical (SEM) Tops Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Select Medical (SEM) delivered earnings and revenue surprises of 16.13% and 3.02%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Can Low Occupancy Rate Affect Select Medical (SEM) Q4 Earnings?

by Zacks Equity Research

Select Medical's (SEM) fourth-quarter results are likely to reflect growing visits in Outpatient Rehabilitation and Concentra.

Select Medical (SEM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Select Medical (SEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Molina (MOH) Surpasses Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Molina (MOH) delivered earnings and revenue surprises of 1.62% and 8.99%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Humana (HUM) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Humana (HUM) delivered earnings and revenue surprises of -57.14% and 1.35%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Strength Seen in Select Medical (SEM): Can Its 11.3% Jump Turn into More Strength?

by Zacks Equity Research

Select Medical (SEM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Select Medical (SEM) Unveils Separation Plan for Concentra

by Zacks Equity Research

Select Medical (SEM) intends to separate its Concentra business in a bid to enhance shareholder value and boost growth prospects of strategically prioritized areas.

Why Select Medical (SEM) is a Top Momentum Stock for the Long-Term

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Here's Why Select Medical (SEM) is a Strong Value Stock

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Why Select Medical (SEM) is a Top Value Stock for the Long-Term

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Select Medical (SEM) Stock Down 6.6% Despite Q3 Earnings Beat

by Zacks Equity Research

Select Medical (SEM) continues to expect adjusted EBITDA to be between $795 million and $825 million in 2023.

Zacks.com featured highlights Select Medical, PVH, Centene, Paysafe and HF Sinclair

by Zacks Equity Research

Select Medical, PVH, Centene, Paysafe and HF Sinclair have been highlighted in this Screen of The Week article.

Zacks.com featured highlights include Select Medical Holdings, Hibbett, PVH and Centene

by Zacks Equity Research

Select Medical Holdings, Hibbett, PVH and Centene are part of the Zacks Screen of the Week article.

Kinjel Shah headshot

5 Low Price-to-Book Stocks to Buy in November

by Kinjel Shah

The P/B ratio helps to identify low-priced stocks that have high growth prospects. Select Medical Holdings Corporation (SEM), PVH Corp. (PVH), Centene (CNC), Paysafe Limited (PSFE) and HF Sinclair Corporation (DINO) are some such stocks.

Sumit Singh headshot

Give Your Investments a Boost With These 4 Low P/CF Stocks

by Sumit Singh

Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. Select Medical (SEM), Hibbett (HIBB), PVH Corp. (PVH) and Centene Corporation (CNC) boast low P/CF ratios.

Humana (HUM) Q3 Earnings Beat on Strong Individual MA Unit

by Zacks Equity Research

Humana (HUM) continues to project 2023 adjusted EPS at a minimum of $28.25, which suggests growth from the 2022 figure of $25.88.

Universal Health (UHS) Q3 Earnings Beat on Adjusted Patient Days

by Zacks Equity Research

Universal Health (UHS) has a leftover repurchase capacity of around $580 million as of Sep 30, 2023.

Select Medical (SEM) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Select Medical (SEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.